Healthcare -
Biotechnology - NASDAQ - US
$ 1.5823
-1.11 %
$ 23.5 M
Market Cap
-0.28
P/E
Price Target
Average
531.99%
Revenue Forecast
Estimate
379.10%
EBIT
Estimate
--45.86%
Net Income
Estimate
27.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Longeveron Inc.
Wall Street analysts predict an average 1-year price target for LGVN of $10 , with forecasts ranging from
a
low of
$10 to a high of $10 .
LGVN Lowest Price Target
Wall Street Target
10 USD
531.99%
LGVN Average Price Target
Wall Street Target
10 USD
531.99%
LGVN Highest Price Target
Wall Street Target
10 USD
531.99%
REVENUE FORECAST
Revenue Forecast Chart LGVN
EBIT FORECAST
EBIT Forecast Chart LGVN
NET INCOME FORECAST
Net Income Chart LGVN